跳至主要内容
临床试验/ITMCTR2100004966
ITMCTR2100004966招募中1 期

A randomized, double-blind, placebo-controlled trial for Xinguan Fuzheng Zhuanyin Decoction to reduce the viral load of the delta variant of COVID-19

Guangdong Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria for COVID-19 (National Eighth Edition);
  • 2. Aged over 18 years;
  • 3. Normal body temperature within 48 hours;
  • 4. In the case of inhaling air, SpO2 > 93%;
  • 5. The onset time is more than 7 days;
  • 6. Sign informed consent.

排除标准

  • 1. The nucleic acid test turns negative twice in a row (24 hours apart);
  • 2. Those who meet the discharge criteria and have a positive nucleic acid after discharge;
  • 3. Severely and critically ill patients (8th edition standard);
  • 4. Abnormal liver and kidney function (more than 2 times the normal value);
  • 5. Allergic to known traditional Chinese medicine;
  • 6. Those who do not cooperate with taking traditional Chinese medicine;
  • 7. Pregnant women.

研究者

发起方
Guangdong Provincial Hospital of Traditional Chinese Medicine

相似试验